Medpace Holdings Inc
NASDAQ:MEDP

Watchlist Manager
Medpace Holdings Inc Logo
Medpace Holdings Inc
NASDAQ:MEDP
Watchlist
Price: 300.98 USD 0.92% Market Closed
Market Cap: 8.7B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one MEDP stock under the Base Case scenario is 369.81 USD. Compared to the current market price of 300.98 USD, Medpace Holdings Inc is Undervalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDP Relative Value
Base Case
369.81 USD
Undervaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.2
P/S
P/S
Price to Sales
4.2
vs History
76
vs Industry
41
Median 3Y
4.7
Median 5Y
4.8
Industry
3.8
Forward
4
More Details
21.5
P/E
P/E
Price to Earnings
21.5
vs History
93
vs Industry
26
Median 3Y
27.2
Median 5Y
30.4
Industry
30.5
Forward
24.1
More Details
15.4
P/OCF
P/OCF
Price to OCF
15.4
vs History
84
vs Industry
34
Median 3Y
18
Median 5Y
19.1
Industry
18.7
More Details
16.6
P/FCFE
P/FCFE
Price to FCFE
16.6
vs History
77
vs Industry
26
Median 3Y
18.7
Median 5Y
22.8
Industry
32.6
More Details
15.1
P/B
P/B
Price to Book Value
15.1
vs History
41
vs Industry
5
Median 3Y
16.3
Median 5Y
12.9
Industry
2.5
More Details
3.9
EV/S
EV/S
Enterprise Value to Sales
3.9
vs History
80
vs Industry
39
Median 3Y
4.5
Median 5Y
4.7
Industry
3.6
Forward
3.8
More Details
12.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.5
vs History
90
vs Industry
27
Median 3Y
15.1
Median 5Y
16.1
Industry
8.3
More Details
17.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.5
vs History
93
vs Industry
25
Median 3Y
21.4
Median 5Y
23.5
Industry
16.6
Forward
17.6
More Details
18.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.7
vs History
95
vs Industry
25
Median 3Y
23.2
Median 5Y
25.6
Industry
22.7
Forward
18.7
More Details
14.6
EV/OCF
EV/OCF
Enterprise Value to OCF
14.6
vs History
88
vs Industry
36
Median 3Y
17.7
Median 5Y
18.9
Industry
17.6
More Details
15.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
15.7
vs History
90
vs Industry
29
Median 3Y
19.7
Median 5Y
21.2
Industry
23.5
More Details
6.1
EV/IC
EV/IC
Enterprise Value to IC
6.1
vs History
33
vs Industry
12
Median 3Y
6
Median 5Y
5.4
Industry
2.3
More Details

Multiples Across Competitors

MEDP Competitors Multiples
Medpace Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Medpace Holdings Inc
NASDAQ:MEDP
9B USD 4.2 21.5 17.5 18.7
US
PerkinElmer Inc
LSE:0KHE
1T USD 377.5 3 648.7 1 279.3 2 609.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
152.9B USD 3.6 23.5 16.5 22.8
US
Danaher Corp
NYSE:DHR
143.9B USD 6 38.2 21 30.6
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 14.5 55.6 32.3 44.9
CH
Lonza Group AG
SIX:LONN
39.4B CHF 6 62.1 22.7 35.4
US
Agilent Technologies Inc
NYSE:A
33.8B USD 5.1 29 19.6 23.2
US
IQVIA Holdings Inc
NYSE:IQV
27.7B USD 1.8 20.8 11.5 17.1
CN
WuXi AppTec Co Ltd
SSE:603259
197.7B CNY 4.7 17.2 17 17
US
Mettler-Toledo International Inc
NYSE:MTD
24.6B USD 6.4 28.9 21.5 23.9
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.5B EUR 6.8 95.3 30.4 53.8

See Also

Summary
MEDP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDP stock valuation using valuation multiples.
Wall Street Estimates
MEDP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 262,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.